1973: First Moments in the Laboratory That Changed Understanding of Starvation
On the morning of February 17, 1973, Dr. John A. L. Carter stood before an electron microscope at the Hospital for Sick Children in Toronto, his hands still trembling after seeing the results of the blood plasma test of a four-month-old boy — almost zero ketone levels, drastic drop in glucose, free fatty acids three times higher. The baby did not suffer from normal hypoglycemia. It did not recover after a glucose injection. It collapsed *after fasting overnight*, not after two days. In the laboratory, Carter and his team found something never seen before: the mitochondria in its hepatocytes were like 'locked' — long-chain fats accumulated outside, unable to enter. They called it 'CPT I deficiency', a name that sounds technical, but in reality was a historical discovery: the first time humans proved that starvation is not just about not eating — it's about *molecular architectural failure*.
Enzyme Built by Evolution, But Forgotten by Genetics
Carnitine palmitoyltransferase I (CPT I) is not just a regular enzyme. It is the main gatekeeper on the outer mitochondrial membrane — a structure inherited from ancient bacteria 1.5 billion years ago. Its original function? To allow prehistoric mammals to survive long cold seasons, when carbohydrates were hard to find and fat became the main energy source. However, on chromosome 11, the *CPT1A* gene — spanning 22 exons, 108 kilobases — is highly sensitive to point mutations. A single change at codon 412 (p.R412W), for example, is enough to weaken the enzyme's binding with malonyl-CoA, a physiological barrier that wisely 'locks' fat burning when the body is full of carbohydrates. In CPT I deficiency patients, this key is *broken from birth*. Thus, even though fat is abundant in the blood, the mitochondria remain starved — like a cargo ship full of rice docked at a port without a crane to unload.
The Inuit Family Story: Evidence That This Deficiency Is Not a 'Disease', But a Trapped Adaptation
In 1994, Canadian researchers revealed a shocking finding: the *CPT1A* p.R412W mutation was found in 69% of the Inuit population in Nunavut — the highest rate in the world. This was no coincidence. Phylogenetic analysis showed that this mutation emerged around 20,000 years ago, during the time when Inuit ancestors migrated to the Arctic. In temperatures of -40°C, their bodies needed ketones as fuel for the brain *and* internal heating. This mutation increased ketone production — an evolutionary advantage. But when new generations of Inuit switched to a Western diet (high in carbohydrates, low in fat), this advantage turned into a danger: the metabolic system trained to 'burn fat continuously' now lost its 'brake' — and clinical CPT I deficiency appeared in babies given glucose-based formula. This story is not just about disease — it is an epic of evolution cut short in mid-course.
From Montreal to Kuala Lumpur: The Trail of a Delayed Diagnosis for 17 Years
In 2006, a baby at Tengku Ampuan Afzan Hospital in Kuantan was reported to collapse after fasting for 14 hours during a glucose tolerance test. Doctors suspected Reye syndrome — until an acylcarnitine profile showed spikes in C16 and C18:0 — clear signs of CPT I failure. In Malaysia, official records of CPT I deficiency were only noted in 2012 in the *Malaysian Journal of Pediatrics*. To date, only 7 cases have been confirmed — not because it is rare, but because most doctors are still looking for classic signs such as seizures or enlarged livers, not subtle symptoms: babies who are 'too calm' after a night's sleep, or children who avoid eating fat without a clear reason. In Singapore, a 2021 study showed that the average diagnosis time was 2.8 years — enough time to cause irreversible neurological damage.
Living Legacy: What Has Been Learned from 50 Years of Research
Since 1973, CPT I deficiency is no longer just a rare diagnosis — it has become a window into understanding how human metabolism dialogues with time, climate, and culture. We now know that patients can live normally with strict management: eating every 3–4 hours, avoiding fasts longer than 8 hours, and ensuring complex carbohydrate intake before bedtime. But more importantly: CPT I deficiency teaches us that genetics is not fate — it is a narrative that can be rewritten with knowledge. As Dr. Marie-Ève Gagnon, a metabolic expert at the University of Montreal, said, 'Every baby with CPT I deficiency is proof that evolution is never finished — it is ongoing, in the treatment room, on the lab bench, and in every breath we take.'
Epilogue: Where Mitochondria Store Memories
Mitochondria are not just 'energy factories'. They are biological archives — storing traces of human migration, climate pressure, and dietary changes over 200,000 years. CPT I deficiency reminds us: what we call 'disease' is often a conflict between genes evolved for the ice age and a world changing too quickly. And in every accurate diagnosis, in every customized meal plan, in every acylcarnitine test read carefully — lies a new form of history: the history of humanity learning to read its own body, letter by letter, mitochondrion by mitochondrion.
*Reference: [Carnitine palmitoyltransferase I deficiency — Wikipedia](https://en.wikipedia.org/wiki/Carnitine_palmitoyltransferase_I_deficiency)*
Why Can This Baby Not Fast Even for an Hour? The Buried Secret of the Enzyme Since 1973. In 1973, a baby in Toronto suddenly collapsed after sleeping without milk for the first night — not due to infection or heart issues, but because an enzyme in its cells failed to open the 'door' for fat to become energy. Now, more than 200 cases have been reported worldwide — and each reveals a surprising truth: the human body is not just a biochemical machine, but a fragile evolutionary archive.. 1973: First Moments in the Laboratory That Changed Understanding of Starvation
On the morning of February 17, 1973, Dr. John A. L. Carter stood before an electron microscope at the Hospital for Sick Children in Toronto, his hands still trembling after seeing the results of the blood plasma test of a four-month-old boy — almost zero ketone levels, drastic drop in glucose, free fatty acids three times higher. The baby did not suffer from normal hypoglycemia. It did not recover after a glucose injection. It collapsed after fasting overnight , not after two days. In the laboratory, Carter and his team found something never seen before: the mitochondria in its hepatocytes were like 'locked' — long-chain fats accumulated outside, unable to enter. They called it 'CPT I deficiency', a name that sounds technical, but in reality was a historical discovery: the first time humans proved that starvation is not just about not eating — it's about molecular architectural failure .
Enzyme Built by Evolution, But Forgotten by Genetics
Carnitine palmitoyltransferase I CPT I is not just a regular enzyme. It is the main gatekeeper on the outer mitochondrial membrane — a structure inherited from ancient bacteria 1.5 billion years ago. Its original function? To allow prehistoric mammals to survive long cold seasons, when carbohydrates were hard to find and fat became the main energy source. However, on chromosome 11, the CPT1A gene — spanning 22 exons, 108 kilobases — is highly sensitive to point mutations. A single change at codon 412 p.R412W , for example, is enough to weaken the enzyme's binding with malonyl-CoA, a physiological barrier that wisely 'locks' fat burning when the body is full of carbohydrates. In CPT I deficiency patients, this key is broken from birth . Thus, even though fat is abundant in the blood, the mitochondria remain starved — like a cargo ship full of rice docked at a port without a crane to unload.
The Inuit Family Story: Evidence That This Deficiency Is Not a 'Disease', But a Trapped Adaptation
In 1994, Canadian researchers revealed a shocking finding: the CPT1A p.R412W mutation was found in 69% of the Inuit population in Nunavut — the highest rate in the world. This was no coincidence. Phylogenetic analysis showed that this mutation emerged around 20,000 years ago, during the time when Inuit ancestors migrated to the Arctic. In temperatures of -40°C, their bodies needed ketones as fuel for the brain and internal heating. This mutation increased ketone production — an evolutionary advantage. But when new generations of Inuit switched to a Western diet high in carbohydrates, low in fat , this advantage turned into a danger: the metabolic system trained to 'burn fat continuously' now lost its 'brake' — and clinical CPT I deficiency appeared in babies given glucose-based formula. This story is not just about disease — it is an epic of evolution cut short in mid-course.
From Montreal to Kuala Lumpur: The Trail of a Delayed Diagnosis for 17 Years
In 2006, a baby at Tengku Ampuan Afzan Hospital in Kuantan was reported to collapse after fasting for 14 hours during a glucose tolerance test. Doctors suspected Reye syndrome — until an acylcarnitine profile showed spikes in C16 and C18:0 — clear signs of CPT I failure. In Malaysia, official records of CPT I deficiency were only noted in 2012 in the Malaysian Journal of Pediatrics . To date, only 7 cases have been confirmed — not because it is rare, but because most doctors are still looking for classic signs such as seizures or enlarged livers, not subtle symptoms: babies who are 'too calm' after a night's sleep, or children who avoid eating fat without a clear reason. In Singapore, a 2021 study showed that the average diagnosis time was 2.8 years — enough time to cause irreversible neurological damage.
Living Legacy: What Has Been Learned from 50 Years of Research
Since 1973, CPT I deficiency is no longer just a rare diagnosis — it has become a window into understanding how human metabolism dialogues with time, climate, and culture. We now know that patients can live normally with strict management: eating every 3–4 hours, avoiding fasts longer than 8 hours, and ensuring complex carbohydrate intake before bedtime. But more importantly: CPT I deficiency teaches us that genetics is not fate — it is a narrative that can be rewritten with knowledge. As Dr. Marie-Ève Gagnon, a metabolic expert at the University of Montreal, said, 'Every baby with CPT I deficiency is proof that evolution is never finished — it is ongoing, in the treatment room, on the lab bench, and in every breath we take.'
Epilogue: Where Mitochondria Store Memories
Mitochondria are not just 'energy factories'. They are biological archives — storing traces of human migration, climate pressure, and dietary changes over 200,000 years. CPT I deficiency reminds us: what we call 'disease' is often a conflict between genes evolved for the ice age and a world changing too quickly. And in every accurate diagnosis, in every customized meal plan, in every acylcarnitine test read carefully — lies a new form of history: the history of humanity learning to read its own body, letter by letter, mitochondrion by mitochondrion.
Reference: Carnitine palmitoyltransferase I deficiency — Wikipedia https://en.wikipedia.org/wiki/Carnitine palmitoyltransferase I deficiency
